Kiora Pharmaceuticals
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -41 | -10 | -38 | -31 |
EBITDA | -2,376 | -5,257 | -2,504 | -2,254 |
EBIT | -2,417 | -5,268 | -2,515 | -2,258 |
Net Income | -2,417 | -6,516 | 26 | -2,152 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -3,166 | -2,258 | -1,273 | -3,835 |
Cash | 10,955 | 8,696 | 5,508 | 1,028 |
Basic Shares | 4,174 | 4,103 | 4,361 | 3,989 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $16,000 | $0 | $0 |
Gross Profit | -24 | 16,000 | -4,027 | -134 |
EBITDA | -12,072 | 5,700 | -12,360 | -13,646 |
EBIT | -12,097 | 5,681 | -12,412 | -13,688 |
Net Income | -10,835 | 3,594 | -12,513 | -13,583 |
Net Change In Cash | 0 | 16,000 | 0 | 0 |
Free Cash Flow | -10,071 | 8,552 | -9,556 | -10,428 |
Cash | 8,696 | 3,792 | 2,454 | 5,964 |
Basic Shares | 4,103 | 4,125 | 538 | 732 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.58 |
2025-12-31 | -$1.73 |
2025-09-30 | $0.01 |
2025-06-30 | -$0.54 |